J&J announces $6.5bn Momenta acquisition, days after Sanofi deal

20-08-2020

Sarah Morgan

J&J announces $6.5bn Momenta acquisition, days after Sanofi deal

sundryphotography / Shutterstock.com

Johnson & Johnson (J&J) is set to buy biotech Massachusetts-based Momenta Pharmaceuticals for $6.5 billion, in a move aimed at strengthening its portfolio of autoimmune disease treatments.


Johnson & Johnson, J&J, Momenta Pharmaceuticals, Sanofi, Principia Biopharma, M&A, mergers and acquisitions, autoimmune, biotech

LSIPR